Arlington Financial Advisors LLC Purchases Shares of 15,524 iShares Biotechnology ETF (NASDAQ:IBB)

Arlington Financial Advisors LLC acquired a new position in iShares Biotechnology ETF (NASDAQ:IBB) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 15,524 shares of the financial services provider’s stock, valued at approximately $2,052,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in IBB. Park Avenue Securities LLC bought a new stake in iShares Biotechnology ETF during the third quarter valued at about $218,000. Albion Financial Group UT lifted its position in shares of iShares Biotechnology ETF by 0.3% in the third quarter. Albion Financial Group UT now owns 129,980 shares of the financial services provider’s stock valued at $18,925,000 after acquiring an additional 356 shares in the last quarter. Valeo Financial Advisors LLC bought a new position in shares of iShares Biotechnology ETF in the third quarter worth about $206,000. CenterStar Asset Management LLC purchased a new stake in shares of iShares Biotechnology ETF during the third quarter worth about $386,000. Finally, Martin Capital Advisors LLP raised its stake in iShares Biotechnology ETF by 1.0% during the 3rd quarter. Martin Capital Advisors LLP now owns 13,169 shares of the financial services provider’s stock valued at $1,918,000 after purchasing an additional 133 shares during the period. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

NASDAQ IBB opened at $137.67 on Friday. iShares Biotechnology ETF has a 12 month low of $123.60 and a 12 month high of $150.57. The stock’s 50 day moving average is $136.22 and its 200 day moving average is $141.41.

iShares Biotechnology ETF Cuts Dividend

The business also recently declared a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were issued a $0.0624 dividend. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.